Background: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports ...

Oral phosphate binding agents have been used for the treatment of hyperphosphatemia in dialysis patients for decades. Their safety record was marred in the early 1980's by reports of aluminium ...